UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

~~May~~June 275, 2025

SAVARA INC.

(Exact name of registrant as specified in its charter)

Delaware

001-32157

84-1318182

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

1717 Langhorne Newtown Road, Suite 300 Langhorne, PA 19047 (Address of principal executive offices, including zip code)

Langhorne, PA 19047

(Address of principal executive offices, including zip code)

(512) 614-1848

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		~~TradingSymbol~~Trading Symbol(s)		Name of each ~~exchangeon~~exchange on which registered
Common Stock, par value $0.001 per share		SVRA		The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8 5.0107. ~~Other~~Submission ~~Events.~~of Matters to a Vote of Security Holders.

OnAt ~~May 27,~~the ~~2025,~~annual ~~Savara~~meeting ~~Inc.~~of ~~issued~~stockholders aof ~~press~~Savara ~~release~~Inc. ~~announcing~~(“Savara”) ~~that~~held iton ~~has~~June 5, ~~received~~2025 ~~a refusal to file letter from~~ (the ~~U.S.~~“Annual ~~Food~~Meeting”), ~~and~~our ~~Drug~~stockholders ~~Administration~~elected ~~for~~each of the ~~Biologics~~following ~~License~~individuals ~~Application for molgramostim inhalation solution~~ to ~~treat~~serve ~~patients~~on ~~with~~the ~~autoimmune~~Board ~~pulmonary~~of ~~alveolar~~Directors ~~proteinosis.~~until ~~A copy of~~ the ~~press~~next ~~release~~annual ismeeting ~~attached~~of ~~hereto~~stockholders, asor ~~Exhibit~~until ~~99.1~~his toor ~~this~~her ~~Current~~successor ~~Report~~is onduly ~~Form~~elected ~~8-K~~ and ~~is incorporated herein by reference~~qualified.

Item 9.01. Financial Statements and Exhibits.


Nominees	Votes For		Votes Against		Abstentions		Broker Non Votes
Matthew Pauls		122,493,658		1,453,636		88,850		27,429,147
Nevan Elam		121,817,142		1,978,211		240,791		27,429,147
Richard J. Hawkins		122,496,649		1,450,704		88,791		27,429,147
Joseph S. McCracken		118,764,349		5,068,271		203,524		27,429,147
David A. Ramsay		122,167,755		1,665,168		203,221		27,429,147
An van Es-Johansson		123,711,996		235,056		89,092		27,429,147

~~(d)~~In ~~Exhibits.~~addition, the following proposals were voted on at the Annual Meeting:

Exhibit No.		Description
99.1		Press Release of Savara Inc. dated May 27, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

1.	Proposal to ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.


Votes For	Votes Against	Abstentions	Broker Non Votes
151,289,378	28,827	147,086	—

2.	Proposal to approve, on an advisory basis, the compensation of our named executives.


Votes For	Votes Against	Abstentions	Broker Non Votes
120,600,997	3,297,958	137,189	27,429,147

3.	Proposal to indicate, on an advisory basis, the preferred frequency of holding an advisory vote on the compensation of our named executives.


1 Year	2 Years	3 Years	Abstentions	Broker Non Votes
122,922,938	101,608	298,734	712,864	27,429,147

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 27, 2025

SAVARA INC. a Delaware corporation

Date: June 6, 2025

SAVARA INC. a Delaware corporation

/s/ Dave Lowrance

Dave Lowrance Chief Financial & Administrative Officer

Filing Compare · Savara Inc